The role of human growth hormone's C-terminal disulfide bridge

Growth Hormone and IGF Research

Volumn 23, Issue 3, 2013, Pages 62-67

  Junnila, R K ^a   Wu, Z ^a   Strasburger, C J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Disulfide bridge; Growth hormone; In vitro

Indexed keywords

DISULFIDE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; STAT5 PROTEIN;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; DIMERIZATION; HORMONE ACTION; HORMONE DETERMINATION; HORMONE STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STABILITY; STRUCTURE ACTIVITY RELATION;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL PROLIFERATION; DISULFIDES; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMAN GROWTH HORMONE; HUMANS; MUTATION; RECEPTORS, SOMATOSTATIN; RECOMBINANT PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84876723402     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2013.02.002     Document Type: Article

References (40)

1. Gahete M.D., Duran-Prado M., Luque R.M., et al. Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology. Ann. N. Y. Acad. Sci. 2009, 1163:137-153.
2. Müller E.E., Locatelli V., Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 1999, 79(2):511-607.
3. Pombo M., Pombo C.M., Garcia A., et al. Hormonal control of growth hormone secretion. Horm. Res. 2001, 55(1):11-16.
4. Brooks A.J., Wooh J.W., Tunny K.A., Waters M.J. Growth hormone receptor; mechanism of action. Int. J. Biochem. Cell Biol. 2008, 40(10):1984-1989.
5. Brown R.J., Adams J.J., Pelekanos R.A., et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 2005, 12(9):814-821.
6. Gent J., van Kerkhof P., Roza M., Bu G., Strous G.J. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(15):9858-9863.
7. Paukku K., Silvennoinen O. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev. 2004, 15(6):435-455.
8. Rosenfeld R.G., Hwa V. The growth hormone cascade and its role in mammalian growth. Horm. Res. 2009, 71(2):36-40.
9. Wells J.A., de Vos A.M. Hematopoietic receptor complexes. Annu. Rev. Biochem. 1996, 65:609-634.
10. Kaplan S.A., Cohen P. The somatomedin hypothesis 2007: 50years later. J. Clin. Endocrinol. Metab. 2007, 92(12):4529-4535.
11. LeRoith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22(1):53-74.
12. Chen E.Y., Liao Y.C., Smith D.H., Barrera-Saldana H.A., Gelinas R.E., Seeburg P.H. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989, 4(4):479-497.
13. Cooke N.E., Coit D., Shine J., Baxter J.D., Martial J.A. Human prolactin. cDNA structural analysis and evolutionary comparisons. J. Biol. Chem. 1981, 256(8):4007-4016.
14. Goffin V., Shiverick K.T., Kelly P.A., Martial J.A. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr. Rev. 1996, 17(4):385-410.
15. Watahiki M., Yamamoto M., Yamakawa M., Tanaka M., Nakashima K. Conserved and unique amino acid residues in the domains of the growth hormones. Flounder growth hormone deduced from the cDNA sequence has the minimal size in the growth hormone prolactin gene family. J. Biol. Chem. 1989, 264(1):312-316.
16. Nicoll C.S., Mayer G.L., Russell S.M. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr. Rev. 1986, 7(2):169-203.
17. Besson A., Salemi S., Deladoey J., et al. Short stature caused by a biologically inactive mutant growth hormone. J. Clin. Endocrinol. Metab. 2005, 90(5):2493-2499.
18. Chen X.Z., Shafer A.W., Yun J.S., Li Y.S., Wagner T.E., Kopchick J.J. Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice. Mol. Endocrinol. 1992, 6(4):598-606.
19. Graf L., Borvendeg J., Barat E., Hermann I., Patthy A. Reactivity and biological importance of the disulfide bonds in human growth hormone. FEBS Lett. 1976, 66(2):233-237.
20. Iliev D.I., Wittekindt N.E., Ranke M.B., Binder G. Structural analysis of human growth hormone with respect to the dominant expression of growth hormone (GH) mutations in isolated GH deficiency type II. Endocrinology 2005, 146(3):1411-1417.
21. Betz S.F. Disulfide bonds and the stability of globular proteins. Protein Sci. 1993, 2(10):1551-1558.
22. Strobl J.S., Thomas M.J. Human growth hormone. Pharmacol. Rev. 1994, 46(1):1-34.
23. Gertler A., Grosclaude J., Strasburger C.J., Nir S., Djiane J. Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J. Biol. Chem. 1996, 271(40):24482-24491.
24. Strasburger C.J., Wu Z., Pflaum C.D., Dressendorfer R.A. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J. Clin. Endocrinol. Metab. 1996, 81(7):2613-2620.
25. Strasburger C.J. Methods in determining growth hormone concentrations: an immunofunctional assay. Pediatrics 1999, 104(4 Pt 2):1024-1028.
26. Rowland J.E., Marshall N.J., Leung K.C., et al. A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays. Clin. Endocrinol. (Oxf) 2002, 56(4):475-485.
27. Maamra M., Finidori J., Von Laue S., et al. Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling. J. Biol. Chem. 1999, 274(21):14791-14798.
28. Ross R.J., Esposito N., Shen X.Y., et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol. Endocrinol. 1997, 11(3):265-273.
29. Ross R.J., Leung K.C., Maamra M., et al. Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer J. Clin. Endocrinol. Metab. 2001, 86(4):1716-1723.
30. Cunningham B.C., Wells J.A. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 1989, 244(4908):1081-1085.
31. Cunningham B.C., Ultsch M., De Vos A.M., Mulkerrin M.G., Clauser K.R., Wells J.A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991, 254(5033):821-825.
32. Petkovic V., Besson A., Thevis M., et al. Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature. J. Clin. Endocrinol. Metab. 2007, 92(8):2893-2901.
33. Petkovic V., Thevis M., Lochmatter D., et al. GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity. Eur. J. Endocrinol. 2007, 157(1):S67-S74.
34. Takahashi Y., Kaji H., Okimura Y., Goji K., Abe H., Chihara K. Brief report: short stature caused by a mutant growth hormone. N. Engl. J. Med. 1996, 334(7):432-436.
35. Sundström M., Lundqvist T., Rodin J., Giebel L.B., Milligan D., Norstedt G. Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9Å resolution. J. Biol. Chem. 1996, 271(50):32197-32203.
36. Baumann G. Growth hormone-binding proteins: state of the art. J. Endocrinol. 1994, 141(1):1-6.
37. Pearce K.H., Cunningham B.C., Fuh G., Teeri T., Wells J.A. Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry 1999, 38(1):81-89.
38. Haugh J.M. Mathematical model of human growth hormone (hGH)-stimulated cell proliferation explains the efficacy of hGH variants as receptor agonists or antagonists. Biotechnol. Prog. 2004, 20(5):1337-1344.
39. Yang N., Langenheim J.F., Wang X., Jiang J., Chen W.Y., Frank S.J. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering. Mol. Endocrinol. 2008, 22(4):978-988.
40. Chantalat L., Jones N.D., Korber F., Navaza J., Pavlovsky A.G. The crystal-structure of wild-type growth-hormone at 2.5 angstrom resolution. Protein Pept. Lett. 1995, 2:333-340.